Feedback sought on 'extensive' revisions to EU qualification/validation GMP for drugs
This article was originally published in SRA
Executive Summary
The European Commission is seeking comments on a number of proposed revisions to the EU guidance on the qualification and validation of facilities, equipment, utilities and processes used for the manufacture of medicines1.